For more information, visit or follow us on LinkedIn and Twitter. Our innovation has been transforming clinical trials for 50 years. Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Clario’s global team of science, technology and operational experts have helped deliver over 24,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more than five million patients in 120 countries. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. MacKenzie’s wealth of experience and knowledge across our industry will be invaluable to Clario as we take this next leap forward.”Ĭlario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. We have pioneered remote data collection so patients can participate in life-changing trials at home, and we are now leading the development and implementation of AI in clinical trial data collection and analysis. Clario’s global team of science, technology and operational experts have helped deliver more than 24,000 trials, and contributed to over 500 FDA and EMEA new drug approvals that have involved more than five million patients in 120 countries. “Few companies can match Clario for experience and scientific expertise. MacKenzie join us as the new Chairman of the Board of Directors,” said Chris Fikry, M.D., CEO of Clario. Alongside other positions, he was previously Chair of the Board of TransCelerate – an industry-wide non-profit focused on accelerating clinical research and was a member of the Executive Committee for Clinical Trials Transformation Initiative, a public-private partnership co-founded by the FDA and Duke University to develop and drive practices that will increase the quality and efficiency of clinical trials. KEY FEATURES: WEB PROTECTION Learn which sites are safe before you open them. HOW CAN CLARIO PROTECT YOU Clario’s powerful security solution is backed up by advanced encryption and IKEv2/IPsec VPN protocols. He led the company’s worldwide development operations, including clinical development and regulatory affairs. Behind Clario’s uniquely intuitive design, lies a powerful toolset that covers your digital security and privacy needs - all in one app. MacKenzie has had a distinguished career in pharmaceutical R&D, most recently holding the position of Chief Development Officer and Executive Vice President at Pfizer Inc.
0 Comments
Leave a Reply. |